A role of transforming growth factor-β1 in the control of corneal neovascularization

In Vivo

Volumn 10, Issue 1, 1996, Pages 59-64

  Friling, Ronit ^a   Yassur, Yuval ^a   Levy, Rachel ^a   Kost, Joseph ^a   Schwartz, Bertha ^a   Mikhailowsky, Rachel ^a   Lamprecht, Sergio A ^a,b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b Faculty of Health Sciences   (Israel)

Author keywords

Angiogenesis; Chemotaxis; Neovascularization; Polymer; Transforming growth factor

Indexed keywords

CYTOCHROME C; DNA; ETHYLENE VINYL ACETATE COPOLYMER; SUPEROXIDE; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1; TRITIUM;

ANGIOGENESIS; ANIMAL EXPERIMENT; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; CORNEA STROMA; DNA SYNTHESIS INHIBITION; DRUG DELIVERY SYSTEM; HUMAN CELL; ISOTOPE LABELING; LUNG ALVEOLUS EPITHELIUM; MALE; MINK; NONHUMAN; PHAGOCYTE; RABBIT; REDUCTION;

EID: 0029951056     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Folkman J, Haudenschild C: Angiogenesis in vitro. Nature 88: 551-556, 1980.
2. Folkman J, Klagsbrun M: Angiogenic factors. Science 235: 442-447, 1987.
3. Massague J: The transforming growth factor-β family. Annu Rev Cell Biol 6: 599-641, 1991.
4. Laiho M, Keski-Oja J: Transforming growth factor-β as regulators of cellular growth and phenotype. Crit Rev Oncogen 3: 1-26, 1991.
5. Roberts AB, Sporn MB: Physiological actions and clinical applications of transforming growth factor-β (TGF-β). Growth Factors 8: 1-9, 1993.
6. Alexandrow MG, Moses HL: Transforming growth factor β and cell cycle regulation. Cancer Res 55: 1452-1457, 1995.
7. Roberts AB, Sporn MB, Assoian RK et al: Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Nat Acad Sci, USA 83 4167-4171, 1986.
8. Yang EY, Moses HL: Transforming growth factor β1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol 111: 731-741, 1990.
9. Madri JA, Pratt BM, Tucker AM: Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix. J Cell Biol 106: 1375-1384, 1988.
10. Merwin JR, Anderson JM, Kocker O et al: Transforming growth factor beta 1 modulates extracellular matrix organization and cell-cell junctional complex formation during in vitro angiogenesis. J Cell Physiol 142: 117-128, 1990.
11. Arispe-Iruela ML, Sage EH: Endothelial cells exhibiting angiogenesis in vitro proliferate in response to TGF-β1. J Cell Biochem 52: 414-430, 1993.
12. Wahl SM, Hunt DA, Wakefield LM et al: Transforming growth factor beta (TGF-β) induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci, USA 84: 5788-5792, 1987.
13. Wiseman DM, Polverini PJ, Kamp DW, et al: Transforming growth factor beta (TGFβ) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem Biophys Res Commun 157: 793-800, 1988.
14. Reibman, J, Meixler S, Lee TC et al: Transforming growth factor beta 1, a potent chemoattractant for human neutrophils, bypasses classic signal-transduction pathways. Proc. Natl. Acad. Sci., USA 88: 6805-6809, 1991.
15. Brandes ME, Mai UEH, Ohura K et al: Type I transforming growth factor-β receptors in neutrophils mediate chemotaxis to transforming growth factors-β. J Immunol 147: 1600-1606, 1991.
16. Wahl SM: Transforming growth factor beta (TGF-β) in inflammation: a cause and a cure. J Clin Immunol 12: 61-74, 1992.
17. Baird A, Durkin T: Inhibition of endothelial cell proliferation by type-beta transforming growth factor: interactions with acidic and basic fibroblast growth factors. Biochem Biophys Res Commun 138: 476-482, 1986.
18. Frater-Schroder M, Muller G, Birchmeier W et al: Transforming growth factor beta inhibits endothelial cell proliferation. Biochem Biophy Res Commun 137: 295-302, 1986.
19. Heimark RL, Twardzik DR, Schwartz S: Inhibition of endothelial cell regeneration by type-beta transforming growth factor from platelets. Science 233: 1078-1080, 1986.
20. Muller G, Behrens J, Nussbaumer J et al: Inhibitory action of transforming growth factor beta on endothelial cells. Proc Natl Acad Sci, USA 84: 5600-5604, 1982.
21. Pepper MS, Belin D, Montesano R et al: Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol 111: 743-755, 1990.
22. Pepper MS, Montesano R, Vassalli JD et al Chondrocytes inhibit endothelial sprout formation in vitro: evidence for involvement of a transforming growth factor-beta. J Cell Physiol 146: 170-179, 1991.
23. Gamble JR, Vadas MA: Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-β. Science 242: 97-99, 1988.
24. Tsunawaki S, Sporn MB, Ding A et al: Deactivation of macrophages by transforming growth factor-β. Nature 334: 260-262, 1988.
25. Rhine W, Hsieh D, Langer R: Polymers for sustained macromolecule release Procedures to fabricate reproducible delivery: systems and control release kinetics. J Pharm Sci 69: 265-270, 1980.
26. Murray Y, Brown L, Langer R: Controlled release of microquantities of macromolecules. Cancer Drug Delivery 1: 119-123, 1984.
27. Gimbrane MA, Cotran RS, Folkman J: Tumor growth and neovascularization: An experimental model using the rabbit cornea. J Natl Cancer Inst 52: 413-419, 1974.
28. Levy R, Schlaeffer F, Keynan A et al: Increased neutrophil function induced by bile duct ligation in a rat model. Hepatology 17: 908-914, 1993.
29. Robinson SD, Silberstein GB, Roberts AB et al: Regulated expression and growth inhibitory effects of transforming growth factor-β isoforms in mouse mammary development. Development 113: 867-878, 1991.
30. Postlethwaite AE, Keski-Oja J, Moses HL et al: Simulation of the chemotactic migration of human fibroblasts by transforming factor β. J Exp Med 165: 251-256, 1987.
31. Grant MB, Khaw RT, Schultz GS et al: Effects of epidermal growth factor, fibroblast growth factor, and transforming growth factor-β on corneal cell chemotaxis. Invest Ophthalmol Vis Sci 133: 3292-3301, 1992.
32. 1 mediates mast cell chemotaxis. J Immunol 152: 5860-5867, 1994.
33. 1) induced neutrophil recruitment to synovial tissues: Implication for TGF-β driven synovial inflammation and hyperplasia. J Exp Med 173: 1121-1132, 1991.
34. Pepper MS, Vassalli JD, Orci L et al: Biphasic effect of transforming growth factor-β on in vitro angiogenesis. Exp Cell Res 204: 356-363, 1993.
35. Gajdusek CM, Luo Z, Mayberg MR: Basic fibroblast growth factor and transforming growth factor beta-1: Synergistic mediators of angiogenesis in vitro. J Cell Physiol 157: 133-144, 1993.
36. Parekh T, Saxena B, Reibman J et al Neutrophil chemotaxis in response to TGF-β isoforms (TGF-β1, TGF-β2, TGF-β3) is mediated by fibronectin. J Immunol 152: 2456-2466, 1994.
37. Moses HL, Yang EY, Pietenpol JA: TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63: 245-247, 1990.
38. Wahl SM, McCartney-Francis N, Mergenhagen SE. Inflammatory and immunomodulatory roles of TGF-β. Immunology Today. 10: 258-261, 1989.
39. Wahl, SM: Transforming growth factor β: The good, the bad and the ugly. J Exp Med 180: 1587-1590, 1994.
40. Haralson MA: Extra cellular matrix and growth factors: an integrated interplay controlling tissue repair and progression to disease. Lab Inv 69: 369-372, 1993.
41. Sporn MB, Roberts AB: Peptide growth factors are multifunctional. Nature 352: 217-218, 1988.
42. Nathan C, Sporn M: Cytokines in context. J Cell Biol 113: 981-986, 1991.
43. Woost PG, Jumblatt MM, Eiferman RA et al: I. Stimulation of bovine corneal endothelial cell DNA synthesis by defined growth factors. Cornea 11: 1-10, 1992.
44. Hopponreiij VT, Pels E, Vrensen FJM et al: Basic fibroblast growth factor stimulates corneal endothelial cell growth and endothelial wound healing of human corneas. Invest Ophthalmol Vis Sci 35: 931-944, 1994.
45. Phillips GD, Stone MA, Jones BD et al: Vascular endothelial growth factor (rhVEGF165) stimulates direct angiogencsis in the rabbit cornea. In Vivo 8: 961-966, 1994.
46. Nguyen N, Goldberg M, Pico J et al: Topical and subcutaneous α-interferon fails to suppress corneal neovascularization. Cornea 14: 147-151, 1995.
47. 3 in the anterior segment of the human eye. Invest Ophthalmol Vis Sci 34: 23-30, 1993.
48. 3 latency-associated peptide in human cornea. Invest Ophthalmol Vis Sci 35: 3289-3294, 1994.
49. Cousins S, McCabe MM, Danielpour D et al: Identification of transforming growth factor beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci 32- 2201-2211, 1991.
50. Tripathi RC, Li J, Borisuth NSC et al: Trabecular cells of the eye express messenger RNA for transforming growth factor β 1 and secrete this cytokine. Invest Ophthalmol Vis Sci 34: 2562-2569, 1993.
51. Peress NS, Perillo E: TGF-β 2 and TGF-β 3 immunoreactivity within the ciliary epithelium. Invest Ophthalmol Vis Sci 35: 453-457, 1994.
52. Lutty GA, Merges C, Threlkeld AB et al: Heterogeneity in localization of isoforms of TGF-β in human retina, vitreous, and chloroid. Invest Ophthalmol Vis Sci 34: 477-487, 1993.
53. 3 mRNA expression in human cornea. Current Eye Res 13: 235-241, 1995.